1. Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel
- Author
-
Thomas Vogl, Verena Müller, Marc Schmidt, Sandrine Tchaptchet, Matthias Goebeler, Johannes Roth, Arne Skerra, Stefan F. Martin, Peter J. Nielsen, Marina A. Freudenberg, Chris Galanos, Simone Keck, Badrinarayanan Raghavan, György Fejer, and Christoph Kalis
- Subjects
Models, Molecular ,Lipopolysaccharide ,Molecular Sequence Data ,Immunology ,Mice, Transgenic ,Biology ,Dermatitis, Contact ,Proinflammatory cytokine ,Mice ,chemistry.chemical_compound ,Immune system ,Nickel ,medicine ,Animals ,Humans ,Immunology and Allergy ,Amino Acid Sequence ,Receptor ,Sensitization ,Toll-like receptor ,Recombinant Proteins ,Cell biology ,Toll-Like Receptor 4 ,Disease Models, Animal ,medicine.anatomical_structure ,chemistry ,TLR4 ,lipids (amino acids, peptides, and proteins) ,Signal transduction ,Signal Transduction - Abstract
Allergies to nickel (Ni(2+)) are the most frequent cause of contact hypersensitivity (CHS) in industrialized countries. The efficient development of CHS requires both a T lymphocyte-specific signal and a proinflammatory signal. Here we show that Ni(2+) triggered an inflammatory response by directly activating human Toll-like receptor 4 (TLR4). Ni(2+)-induced TLR4 activation was species-specific, as mouse TLR4 could not generate this response. Studies with mutant TLR4 proteins revealed that the non-conserved histidines 456 and 458 of human TLR4 are required for activation by Ni(2+) but not by the natural ligand lipopolysaccharide. Accordingly, transgenic expression of human TLR4 in TLR4-deficient mice allowed efficient sensitization to Ni(2+) and elicitation of CHS. Our data implicate site-specific human TLR4 inhibition as a potential strategy for therapeutic intervention in CHS that would not affect vital immune responses.
- Published
- 2010
- Full Text
- View/download PDF